National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 14259-14260 [2014-05473]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 49 / Thursday, March 13, 2014 / Notices
TKELLEY on DSK3SPTVN1PROD with NOTICES
Computer Controlled Aerosol
Generator With Multi-Walled Carbon
Nanotube Inhalation Testing
Capabilities
Description of Technology: This
invention pertains to a CDC–NIOSH
developed sonic aerosol generator that
provides a controllable, stable
concentration of particulate aerosol over
a long period of time for aerosol
exposure studies. Specifically, in situ
testing data indicate uniform aerosol
stability can be maintainable for greater
than 30 hours at concentrations of 15
mg/m3 or more. Additionally, the
technology was specifically developed
for, and validated in, animal studies
assessing exposure to airborne multiwalled carbon nanotubes (MWCNT). It
has been suggested that workers may be
at risk for exposure to nanosized
particles during the manufacture,
handling, and cleanup of engineered
nanomaterials. Compared to other
technologies, this NIOSH aerosol
generator is particularly helpful when
used for generating high testing
concentrations of MWCNT aerosols that
more accurately represent particulate
levels that may be seen in a workplace
environment.
Potential Commercial Applications:
• Studying the size and shape of the
aerosolized particles produced from
simple vibrations of bulk material
• Toxicological investigations and risk
assessment of aerosol exposures,
especially those related to
nanoparticle manufacturing.
• Any aerosolization application where
the aggregating ‘‘bird’s nest’’
tendencies of airborne multi-walled
carbon nanotubes must be overcome
Competitive Advantages:
• Fully automated system with
integrated feedback control for
optimized stability in testing
• Maintains concentration of aerosols
for >30 hours at concentrations of 15
mg/cubic meter or more
• Capable of generating high
concentrations of aerosols that more
accurately represent the levels seen in
a workplace environment
• System insures that each run
produces a constant particle
concentration, air flow, pressure,
temperature and humidity within a
testing chamber
Development Stage:
• In vitro data available
• In vivo data available (animal)
• In situ data available (on-site)
• Prototype
Inventors: Walter G. McKinney, David
G. Frazer, Bean Chen (all of CDC)
Publications:
VerDate Mar<15>2010
17:33 Mar 12, 2014
Jkt 232001
1. McKinney W, et al. Computer controlled
multi-walled carbon nanotube inhalation
exposure system. Inhal Toxicol. 2009
Oct;21(12):1053–61. [PMID 19555230]
2. Porter DW, et al. Acute pulmonary doseresponses to inhaled multi-walled
carbon nanotubes. Nanotoxicology. 2013
Nov;7:1179–94. [PMID 22881873]
3. Porter DW, et al. Mouse pulmonary doseand time course-responses induced by
exposure to multi-walled carbon
nanotubes. Toxicology. 2010 Mar
10;269(2–3):136–47. [PMID 19857541]
4. Chen BT, et al. Multi-walled carbon
nanotubes: sampling criteria and aerosol
characterization. Inhal Toxicol. 2012
Oct;24(12):798–820. [PMID 23033994]
Intellectual Property: HHS Reference
No. E–156–2013/0—U.S. Patent
Application No. 12/871,453 filed 30
Aug 2010.
Licensing Contact: Whitney Blair, J.D.,
M.P.H.; 301–435–4937; whitney.blair@
nih.gov.
Dated: March 10, 2014.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2014–05472 Filed 3–12–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Collaborative
Perinatal Project (CPP) Mortality Linkage
Study Data Coordinating Center.
Date: April 8, 2014.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To provide concept review of
proposed concept review.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy,
Ph.D., Scientific Review Officer, Division of
Scientific Review, National Institute of Child
Health and Human Development, 6100
Executive Boulevard, Rockville, MD 20892–
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
14259
9304, (301) 435–6680, skandasa@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS).
Dated: March 7, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–05474 Filed 3–12–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Resource-Related Research Projects in Lung
Diseases.
Date: April 8, 2014.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, MD 20015.
Contact Person: Susan Wohler Sunnarborg,
Ph.D. Scientific Review Officer, Office of
Scientific Review/DERA, National, Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7182, Bethesda, MD 20892
sunnarborgsw@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Ancillary Studies in Clinical Trials.
Date: April 11, 2014.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Washington DC/
Bethesda, 7301 Waverly St., Bethesda, MD
20814.
Contact Person: Kristen Page, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
E:\FR\FM\13MRN1.SGM
13MRN1
14260
Federal Register / Vol. 79, No. 49 / Thursday, March 13, 2014 / Notices
Blood Institute, 6701 Rockledge Drive, Room
7185, Bethesda, MD 20892, 301–435–0725,
kristen.page@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS).
Dated: March 7, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–05473 Filed 3–12–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
TKELLEY on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Loan Repayment
Program.
Date: April 15, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy,
Ph.D., Scientific Review Officer, Division of
Scientific Review, National Institute of Child
Health and Human Development, 6100
Executive Boulevard, Rockville, MD 20892–
9304, (301) 435–6680, skandasa@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS).
VerDate Mar<15>2010
17:33 Mar 12, 2014
Jkt 232001
Dated: March 7, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–05475 Filed 3–12–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel.
Date: April 9, 2014.
Time: 11:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Marita R. Hopmann, Ph.D.,
Scientific Review Administrator, Division of
Scientific Review, National Institute of Child
Health and Human Development, 6100
Building, Room 5B01, Bethesda, MD 20892,
(301) 435–6911, hopmannm@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Pelvic Floor
Disorders Review.
Date: April 10, 2014.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: David Weinberg, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD 20892,
301–435–6973, David.Weinberg@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Mouse model of
Dyslexia Risk Genes.
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Date: April 11, 2014.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: David Weinberg, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD 20892,
301–435–6973, David.Weinberg@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Research on
tuberculosis for HIV-infected mothers and
children in India.
Date: April 14, 2014.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Rita Anand, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100
Executive Blvd. Room 5B01, Bethesda, MD
20892, (301) 496–1487,
anandr@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Routes to Improving
Population Health.
Date: April 16, 2014.
Time: 11:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Carla T. Walls, Ph.D.,
Scientific Review Administrator, Division of
Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD
20892, (301) 435–6898, wallsc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: March 7, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–05476 Filed 3–12–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\13MRN1.SGM
13MRN1
]]>Agencies
[Federal Register Volume 79, Number 49 (Thursday, March 13, 2014)]
[Notices]
[Pages 14259-14260]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05473]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Resource-Related Research Projects in Lung
Diseases.
Date: April 8, 2014.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites Chevy Chase Pavilion, 4300 Military Road
NW., Washington, MD 20015.
Contact Person: Susan Wohler Sunnarborg, Ph.D. Scientific Review
Officer, Office of Scientific Review/DERA, National, Heart, Lung,
and Blood Institute, 6701 Rockledge Drive, Room 7182, Bethesda, MD
20892 sunnarborgsw@nhlbi.nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Ancillary Studies in Clinical Trials.
Date: April 11, 2014.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Garden Inn Washington DC/Bethesda, 7301 Waverly
St., Bethesda, MD 20814.
Contact Person: Kristen Page, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and
[[Page 14260]]
Blood Institute, 6701 Rockledge Drive, Room 7185, Bethesda, MD
20892, 301-435-0725, kristen.page@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS).
Dated: March 7, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-05473 Filed 3-12-14; 8:45 am]
BILLING CODE 4140-01-P
